These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22458996)

  • 1. Hepatic dysfunction and survival after orthotopic heart transplantation: application of the MELD scoring system for outcome prediction.
    Chokshi A; Cheema FH; Schaefle KJ; Jiang J; Collado E; Shahzad K; Khawaja T; Farr M; Takayama H; Naka Y; Mancini DM; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):591-600. PubMed ID: 22458996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liver dysfunction as a predictor of outcomes in patients with advanced heart failure requiring ventricular assist device support: Use of the Model of End-stage Liver Disease (MELD) and MELD eXcluding INR (MELD-XI) scoring system.
    Yang JA; Kato TS; Shulman BP; Takayama H; Farr M; Jorde UP; Mancini DM; Naka Y; Schulze PC
    J Heart Lung Transplant; 2012 Jun; 31(6):601-10. PubMed ID: 22458997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD-XI score and cardiac mortality or transplantation in patients after Fontan surgery.
    Assenza GE; Graham DA; Landzberg MJ; Valente AM; Singh MN; Bashir A; Fernandes S; Mortele KJ; Ukomadu C; Volpe M; Wu F
    Heart; 2013 Apr; 99(7):491-6. PubMed ID: 23406689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher Transaminase Levels in the Postoperative Period After Orthotopic Heart Transplantation Are Associated With Worse Survival.
    Holndonner-Kirst E; Nagy A; Czobor NR; Fazekas L; Lex DJ; Sax B; Hartyanszky I; Merkely B; Gal J; Szekely A
    J Cardiothorac Vasc Anesth; 2018 Aug; 32(4):1711-1718. PubMed ID: 29433797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Model for End-Stage Liver Disease eXcluding INR (MELD-XI) Score Predicts Early Death After Pediatric Heart Transplantation.
    Grimm JC; Magruder JT; Do N; Spinner JA; Dungan SP; Kilic A; Patel N; Nelson KL; Jacobs ML; Cameron DE; Vricella LA
    Ann Thorac Surg; 2016 Feb; 101(2):730-5. PubMed ID: 26347119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of liver biopsy with MELD-XI scores for post-transplant outcome prediction in patients with advanced heart failure and suspected liver dysfunction.
    Farr M; Mitchell J; Lippel M; Kato TS; Jin Z; Ippolito P; Dove L; Jorde UP; Takayama H; Emond J; Naka Y; Mancini D; Lefkowitch JH; Schulze PC
    J Heart Lung Transplant; 2015 Jul; 34(7):873-82. PubMed ID: 25851466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic dysfunction in ambulatory patients with heart failure: application of the MELD scoring system for outcome prediction.
    Kim MS; Kato TS; Farr M; Wu C; Givens RC; Collado E; Mancini DM; Schulze PC
    J Am Coll Cardiol; 2013 Jun; 61(22):2253-2261. PubMed ID: 23563127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting early allograft failure and mortality after liver transplantation: the role of the postoperative model for end-stage liver disease score.
    Wagener G; Raffel B; Young AT; Minhaz M; Emond J
    Liver Transpl; 2013 May; 19(5):534-42. PubMed ID: 23576469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic utility of MELD-XI in adult congenital heart disease patients undergoing cardiac transplantation.
    Adams ED; Jackson NJ; Young T; DePasquale EC; Reardon LC
    Clin Transplant; 2018 Jun; 32(6):e13257. PubMed ID: 29660764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The application of MELD score in patients submitted to liver transplantation: a retrospective analysis of survival and the predictive factors in the short and long term].
    Boin Ide F; Leonardi MI; Udo EY; Sevá-Pereira T; Stucchi RS; Leonardi LS
    Arq Gastroenterol; 2008; 45(4):275-83. PubMed ID: 19148354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver dysfunction assessed by model for end-stage liver disease excluding INR (MELD-XI) scoring system predicts adverse prognosis in heart failure.
    Abe S; Yoshihisa A; Takiguchi M; Shimizu T; Nakamura Y; Yamauchi H; Iwaya S; Owada T; Miyata M; Sato T; Suzuki S; Oikawa M; Kobayashi A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh S; Takeishi Y
    PLoS One; 2014; 9(6):e100618. PubMed ID: 24955578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive Value of the Model for End-Stage Liver Disease Score Excluding International Normalized Ratio One Year After Orthotopic Heart Transplantation.
    Szyguła-Jurkiewicz B; Zakliczyński M; Szczurek W; Nadziakiewicz P; Gąsior M; Zembala M
    Transplant Proc; 2016 Jun; 48(5):1703-7. PubMed ID: 27496475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.
    Rostved AA; Lundgren JD; Hillingsø J; Peters L; Mocroft A; Rasmussen A
    Scand J Gastroenterol; 2016 Nov; 51(11):1360-6. PubMed ID: 27319374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical course of congestive hepatopathy pre/post heart transplantation.
    Balcar L; Semmler G; Scheiner B; Stättermayer AF; Ćosić S; Schwabl P; Kazem N; Mandorfer M; Hülsmann M; Zuckermann A; Reiberger T
    Wien Klin Wochenschr; 2024 May; 136(9-10):267-277. PubMed ID: 37378679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
    Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
    Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of pre and post-implant MELD-XI score on survival in children undergoing VAD implantation.
    Amdani S; Boyle GJ; Cantor RS; Conway J; Godown J; Kirklin JK; Koehl D; Lal AK; Law Y; Lorts A; Rosenthal DN
    J Heart Lung Transplant; 2021 Dec; 40(12):1614-1624. PubMed ID: 34598872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Model of End-Stage Liver Disease-eXcluding International Normalized Ratio (MELD-XI) Scoring System to Predict Outcomes in Patients Who Undergo Left Ventricular Assist Device Implantation.
    Critsinelis A; Kurihara C; Volkovicher N; Kawabori M; Sugiura T; Manon M; Wang S; Civitello AB; Morgan JA
    Ann Thorac Surg; 2018 Aug; 106(2):513-519. PubMed ID: 29626453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HeartMate II left ventricular assist device implantation in patients with advanced hepatic dysfunction.
    Demirozu ZT; Hernandez R; Mallidi HR; Singh SK; Radovancevic R; Segura AM; Etheridge WB; Cohn WE; Frazier OH
    J Card Surg; 2014 May; 29(3):419-23. PubMed ID: 24641429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year native liver survival analysis in biliary atresia from a single large Chinese center: The death/liver transplantation hazard change and the importance of rapid early clearance of jaundice.
    Wang Z; Chen Y; Peng C; Pang W; Zhang T; Wu D; Shen Q; Li M
    J Pediatr Surg; 2019 Aug; 54(8):1680-1685. PubMed ID: 30518490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac hepatopathy before and after heart transplantation.
    Dichtl W; Vogel W; Dunst KM; Grander W; Alber HF; Frick M; Antretter H; Laufer G; Pachinger O; Pölzl G
    Transpl Int; 2005 Jun; 18(6):697-702. PubMed ID: 15910296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.